Lupin’s arm enters into agreement with TTP pie

02 Dec 2021 Evaluate

Lupin’s wholly-owned subsidiary -- Lupin Inc has entered into an agreement with TTP pie (The Technology Partnership pie) to acquire the exclusive worldwide rights to develop, manufacture and commercialize Inhalation products using TTP's soft-mist inhalation technology platform.

By leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable Inhaled medicines to patients across the globe. Lupin and TTP will jointly develop the device. Lupin will commercially manufacture the device through its network of in-house and external manufacturing locations. Lupin will also develop and manufacture formulations to be delivered through the device, obtain the necessary regulatory approvals, and commercialize the products globally. 

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×